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COVER  Early results show a new non-
invasive therapy — delivered in 10 minutes or 
less — is halting arrhythmia when standard 
treatments have failed. A vest (above), covered 
in 252 electrodes, produces a panoramic map 
of a patient’s heart. Doctors use this map to 
direct a radiation beam at the heart, zapping 
malfunctioning cells. See page 14. 
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Sylvia, 12, tries on a medallion commemorating a 
professorship in her grandfather’s name, while family 
members look on. Big sister Mackenzie (background, 
center) is joining the freshman class this fall.  
The family established the Daniel J. Brennan, MD, 
Professorship in Neurology. See page 30.
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In a well-choreographed move 
Jan. 27, sta members transported 
babies one at a time — about  
10 infants an hour — from the 
newborn intensive care unit (NICU) 
at St. Louis Children’s Hospital to 
the hospital’s expanded NICU. 
Now, a 100-foot skywalk connects 
the NICU with labor and delivery  
in the new Barnes-Jewish 
Parkview Tower.  See page 20.
As inaugural director of the 
Institute for Informatics, Philip R.O. 
Payne, PhD, is charting a new path 
forward for big data initiatives at 
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eople with Alzheimer’s disease 
are known to have circadian 
clock disturbances that affect the 
sleep/wake cycle. New research indicates 
that such disruptions also occur much 
earlier in people whose memories are 
intact but whose brain scans show 
preclinical evidence of Alzheimer’s.
The findings could help doctors identify 
people at risk of Alzheimer’s, a disease that 
can take root in the brain 15 to 20 years 
before clinical symptoms appear.
The research was published Jan. 29 in 
the journal JAMA Neurology.
“It wasn’t that the people in the study 
were sleep-deprived,” said first author Erik 
S. Musiek, MD, PhD, an assistant professor 
of neurology. “But their sleep tended to be 
fragmented. Sleeping solidly for eight 
hours is very different from getting eight 
hours of sleep in one-hour increments.”
The researchers conducted a separate 
study in mice, published in The Journal of 
Experimental Medicine, showing that 
circadian disruptions accelerate the 
development of amyloid plaques in the 
brain — a process linked to Alzheimer’s.
Previous studies at Washington 
University, conducted in people and in 
animals, have found that amyloid levels 
fluctuate predictably during the day and 
night — decreasing during sleep and 
increasing when sleep is disrupted or when 
people don’t get enough deep sleep.
In this work, the researchers tracked 
circadian rhythms in 189 cognitively normal, 
older adults with an average age of 66. 
Some had positron emission tomography 
(PET) scans to look for Alzheimer’s-related 
amyloid plaques in their brains. Others had 
their cerebrospinal fluid tested for Alzheimer’s- 
related proteins. And some had scans and 
spinal fluid testing.
Of the participants, 139 had no evidence 
of the amyloid protein that signifies 
preclinical Alzheimer’s. Most had normal 
sleep/wake cycles, although several had 
circadian disruptions that were linked to 
advanced age, sleep apnea or other causes.
But among the other 50 subjects — 
who either had abnormal brain scans or 
abnormal cerebrospinal fluid — all 
experienced significant disruptions in their 
internal body clocks, determined by how 
much rest they got at night and how active 
they were during the day. 
The researchers said it’s too early to 
determine whether disrupted circadian 
rhythms put people at risk for Alzheimer’s 
disease or vice versa.
pulse
Body clock disruptions may be rst sign 
P
Changes could ID Alzheimer’s risk sooner — years before memory loss
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Temporarily shutting o neuronal signals to a healthy  
part of the brain may aid stroke recovery, according to  
new research in mice.
Mice that had experienced strokes were more likely to 
recover the ability to use a front paw if their whiskers were 
clipped following a stroke. Trimming the whiskers deprives  
an area of the mouse’s brain from receiving sensory signals. 
And it leaves that area of the brain more plastic — or 
receptive to rewiring to take on new tasks.
“We may have to rethink how we do stroke rehabilitation,”  
said senior author Jin-Moo Lee, MD, PhD, the Norman J.  
Stupp Professor of Neurology. “Stroke rehab oen focuses on 
trying to train patients to compensate for disability caused 
by the stroke, but this strategy has limited eectiveness.  
Our ndings suggest that we may be able to stimulate 
recovery by temporarily vacating some brain real estate  
and making that region of the brain more plastic. One  
way to do that might be by immobilizing a healthy limb.”
e researchers triggered, in mice, a stroke in the part 
of the brain that controls the right forepaw. en, they 
trimmed the whiskers in half of the mice. Immediately aer 
the strokes, both groups of mice favored their le forepaws. 
But by four weeks aer the strokes, those with clipped 
whiskers had begun using their right forepaws again, and 
by eight weeks, they were back to using both equally. In 
contrast, mice whose whiskers were not clipped showed  
no improvement at four weeks and only partial recovery  
at eight weeks.
Brain mapping revealed that, in each mouse with 
trimmed whiskers, the locus of forepaw control had taken 
over part of the area that usually receives whisker sensation. 
“Maybe we need to start thinking about improving 
outcomes by enhancing plasticity in targeted regions of  
the brain,” Lee said. 
A new drug compound — that dials 
down inammation and is more 
selective than other compounds 
targeting the same inammatory 
pathway — might be useful against 
autoimmune disorders such as 
rheumatoid arthritis, according to 
School of Medicine research. 
e protein p38 MAPK helps tissue 
remain healthy, but when chronically 
switched on, it attacks the body’s own 
tissues. Because this protein drives 
inammation in many disorders, 
drug companies have developed 
compounds to block its signaling. 
ese compounds work for a while, 
but eventually the body recalibrates 
and inammation returns.
Rather than blocking the entire 
pathway, the new compound, CDD-
450, hits just one of several branches 
a bit downstream of the p38 MAPK 
protein. Blocking that pathway 
while allowing the other branches 
to operate freely may remedy the 
inammation recalibration problem.
Studying mice, rats and human 
cells, the researchers found that  
the compound reduces levels of 
inammatory signaling molecules. e scientists further 
showed that it prevents the destruction of bones and 
joints in a rat model of rheumatoid arthritis.
Developed by Conuence Discovery Technologies Inc., 
the compound is novel because it is not a global inhibitor 
of the protein, said Gabriel Mbalaviele, PhD, an associate 
professor of medicine and company co-founder. 
CDD-450 could be taken by mouth, unlike some anti-
inammatory treatments called biologics that must be 
injected into the bloodstream. Also, because biologics 
are made of short protein sequences, the immune system 
may recognize them as foreign and eliminate them, 
resulting in resistance buildup. e new inhibitor, a 
small molecule, bears no resemblance to proteins. 
Aclaris erapeutics Inc. recently acquired 
Conuence and is moving toward clinical trials to test 
the safety of CDD-450 (now called ATI-450). 
Drug compound shows 
promise against arthritis
Researchers helped mice recover faster from stroke by clipping their whiskers, an 
important sensory organ. The above images show brain mapping at eight weeks 
post-stroke in mice with whiskers intact (left) and with trimmed whiskers.
3D CT scans of rat paws show 
(from top to bottom): a normal 
joint; the effects of rheuma-
toid arthritis;  reduced damage 










Stroke recovery improved 
by sensory deprivation
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Michael G. Caparon Jr., PhD
Professor of molecular microbiology
Honored for his studies of disease-causing bacteria, 
such as those that cause strep throat, scarlet fever  
and urinary tract infections. 
Graham A. Colditz, MD, DrPH
Niess-Gain Professor of Surgery and chief of the  
Division of Public Health Sciences
Honored for contributions to cancer epidemiology  
and prevention. 
John A. Cooper, MD, PhD
Professor and head of the Department of Biochemistry and 
Molecular Biophysics
Honored for contributions to the field of cell motility and the 
cytoskeleton, particularly for actin assembly and function. 
Michael S. Diamond, MD, PhD
Herbert S. Gasser Professor of Medicine
Honored for his studies of how viruses such as  
West Nile, Zika, dengue and chikungunya evade the 
immune system and cause disease.
Susan K. Dutcher, PhD
Professor of genetics and the interim director of the  
McDonnell Genome Institute
Honored for contributions to the field of cell biology, 
particularly for studies examining the assembly and 
function of cilia. 
Timothy J. Eberlein, MD
Bixby Professor of Surgery and head of the Department  
of Surgery; director of Siteman Cancer Center
Honored as a pioneering, national leader in  
surgery education, research and publishing, and  
in development of cancer center networks,  
research programs and clinical protocols. 
Michael L. Gross, PhD
Professor of chemistry in Arts & Sciences and of immunology and 
pathology and of medicine in the School of Medicine
Recognized for contributions to physical-organic, 
analytical, environmental and biophysical chemistry by 
developing and applying mass-spectrometry methods. 
Seven faculty named
2017 AAAS fellows
Seven faculty members are among 396 new fellows selected 
by the American Association for the Advancement of Science 
(AAAS), the world’s largest general scientific society. 
STANDING IN SOLIDARITY  Students joined in 
the March 14 walk-out/die-in to remember the victims of the 
Parkland, Florida, shooting and call attention to gun violence 
as a public health crisis. They also advocated for a stronger 








Despite public health campaigns aimed at reducing 
unnecessary prescriptions, antibiotics continue to be 
prescribed at startlingly high rates in outpatient settings, 
according to a new study.
e researchers analyzed de-identied data from Express 
Scripts Holding Co. and found that 98 million outpatient 
antibiotic prescriptions were lled by 39 million people during 
a three-year period from 2013 to 2015. ey found no decline 
in the overall antibiotic prescription rate during that time.
“is study suggests that current guidelines on prescribing 
antibiotics are not being followed,” said Michael Durkin, 
MD, assistant professor of medicine and co-director of the 
Antimicrobial Stewardship Program at Barnes-Jewish Hospital. 
e data tracked monthly prescription rates for all 
antibiotics, including the ve most prescribed in outpatient 
settings: azithromycin, amoxicillin, amoxicillin/clavulanate, 
ciprooxacin and cephalexin.
e CDC estimates that up to 30 percent of antibiotic 
prescriptions in outpatient settings may be unnecessary, such 
as those written for sore throats and sinus infections, which 
most oen are caused by viruses. Overuse contributes to the 
rise of drug-resistant superbugs and excess health-care costs. 
e researchers are conducting further studies to understand 
the gap between guidelines and prescribing practices.
No progress seen in reducing  
antibiotics among outpatients
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Wonderfully weird
Students got creepy and kooky, mysterious 
and spooky and altogether ooky in their 
performance of “The Addams Family Musical” 
in March. The production, a culmination of a 
yearlong planning process, involved students 
from all educational programs on the Medical 
Campus. This was the 13th year for the show, 
which is entirely student-produced. Students 
build sets, sew costumes, run light and sound, 
play in the pit orchestra, direct and act. Left: 
Uncle Fester, as played by Matt Mosley, a student 
in the Division of Biology & Biomedical Sciences.
epsis — a condition that develops 
when an infection triggers an 
overwhelming immune response — 
causes about 250,000 deaths annually in the 
U.S. Standard treatment, involving high doses 
of antibiotics, often doesn’t work well and 
fails to boost the body’s immune defenses.
Now, a drug that revs up the immune 
system is showing promise in a small clinical 
trial. The approach goes against the grain 
of earlier strategies that have relied on 
antibiotics and inflammatory medications to 
tamp down the immune system.
“Mortality rates from sepsis have remained 
essentially the same over the last 50 years,” 
said senior investigator Richard S. Hotchkiss, 
MD, a professor of anesthesiology, of medicine 
and of surgery. “Hundreds of drugs have 
been tried and have failed. It may sound 
counterintuitive when inflammation is such 
a problem early in sepsis, but our approach is 
to stimulate certain immune cells to help the 
patient’s system take control of the infection.”
The trial involved 27 sepsis patients, ages 
33 to 82, who were treated at Barnes-Jewish 
Hospital, Vanderbilt University Medical Center 
in Nashville or two medical centers in France 
— Dupuytren University Hospital in Limoges 
and Edouard Herriot Hospital in Lyon. 
New way to ght sepsis: Rev up immune systems
Clinical trial demonstrates significant, lasting increase in key immune cells
The patients 
were treated with 




and survival of 
immune cells 
CD4 and CD8. 
These cells are 
important because 
they recruit other 
immune cells 
to fight severe 
infections that 
can lead to organ failure and death. Patients 
who develop the most serious form of sepsis, 
called septic shock, often have very low 
counts of these key immune cells. 
The trial patients, all hospitalized and 
severely ill with septic shock, were randomly 
assigned to one of two therapies. Seventeen 
patients received the IL-7 drug, and 10 
received a standard treatment. Those who 
received the IL-7 drug experienced a threefold 
to fourfold increase in CD4 and CD8 counts.
Traditional approaches do not address 
the critical problem of patients’ severely 
compromised immune systems. Without 
restoring immune function, Hotchkiss said, 
many patients develop lingering infections 
and are helpless to fight any new infections.
A larger trial is being planned to determine 
whether IL-7 can improve survival rates.
A small clinical trial led by Richard S. Hotchkiss, MD, 
shows that a drug that revs up the immune system 
holds promise in treating sepsis. From left, Hotchkiss, 
an ICU doctor for the past 30 years, his clinical trial 
patient, Greg Porter, who recovered from sepsis, and 
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Last year, the Food and Drug Administration approved 
the rst cellular immunotherapies to treat cancer. ese 
therapies involve collecting a patient’s own immune cells 
— called T cells — and supercharging them to home in on 
and attack specic blood cancers, such as hard-to-treat acute 
lymphoblastic leukemia and non-Hodgkin lymphoma.
But so far, these T cell immunotherapies — called CAR-T 
cells — can’t be used if the T cells themselves are cancerous. 
Even though supercharged T cells can kill cancerous T cells, 
they also can kill each other because they resemble one 
another so closely.
School of Medicine 
scientists now have 
used the gene-editing 
technology CRISPR 
to engineer human T 
cells that can attack 
human T cell cancers 
without succumbing 
to friendly re.
e study in mice 
appears online in the 
journal Leukemia.
Cancerous and 
healthy T cells have the same protein — CD7 — on their 
surfaces. e team, led by senior author John F. DiPersio, 
MD, PhD, the Virginia E. and Sam J. Golman Professor of 
Medicine in Oncology, rst generated a novel CAR-T strategy 
targeting CD7, allowing for the targeting and killing of all 
cells with CD7 on the surface.
“But if we program T cells to target CD7, they would 
attack the cancerous cells and each other, thus undermining 
this approach,” DiPersio said. “To prevent this T cell 
fratricide, we used CRISPR/Cas9 gene editing to remove  
CD7 from healthy T cells, so they no longer carry the target.”
DiPersio and his colleagues also used CRISPR to 
simultaneously eliminate the therapeutic T cells’ ability to 
see healthy tissues as foreign.
is way, T cells from any normal donor can be used 
without risk of life-threatening toxicities such as gra-
versus-host disease. A “matched” donor with similar 
immunity is not required. 
is new approach also may have broad implications for 
the CAR-T eld, allowing for use of therapeutic T cells from 
any healthy donor. 
e researchers demonstrated that this approach is 
eective in mice with T cell acute lymphoblastic leukemia 
taken from patients. ey are working toward clinical trials 
of the gene-edited CAR-T cells. 
CRISPR enhances  
cancer immunotherapy
John DiPersio, MD, PhD, right, works in the lab 













David H. Perlmutter, MD, dean of the 
School of Medicine, will join the likes of 
former President Barack Obama, actor 
Tom Hanks and Supreme Court Justice 
Sonia M. Sotomayor as new members 
of the American Academy of Arts and 
Sciences.
Perlmutter, the Spencer T. and Ann 
W. Olin Distinguished Professor and 
executive vice chancellor for medical aairs, is internationally 
recognized for his research on alpha-1 antitrypsin deciency 
(ATD), a genetic disorder in which the accumulation of a 
misfolded protein in liver cells can result in severe liver failure.
To evaluate potential treatments for ATD, he and 
colleagues developed a pipeline of drugs that includes one  
in a phase II/III clinical trial. e goal is to eliminate the 
need for liver transplantation, the only treatment option  
for patients with progressive liver disease due to ATD.
Perlmutter was trained at Children’s Hospital of 
Philadelphia and Boston Children’s Hospital and has  
been on the faculties of Harvard Medical School and the 
University of Pittsburgh.
e new class will be inducted in October in Cambridge, 
Massachusetts, joining a list that includes Benjamin 
Franklin, Alexander Hamilton, Ralph Waldo Emerson, 
Charles Darwin, Albert Einstein and Martin Luther King Jr. 
EARNING A SPOT  STAT, an online biomedical science 
news publication, chose 64 teams to compete in STAT Madness 2018, 
a March-Madness-esque battle designed to find the most innovative 
scientific and medical research of 2017. Two School of Medicine 
teams made the bracket, and one of them made it to the “Elite 
Eight.” That team, led by Farshid Guilak, PhD (foreground), was 
chosen for research aimed at rewiring stem cells to cure arthritis.
American Academy of Arts and 
Sciences elects Perlmutter
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BIG DATA
Putting information-based tools in doctors’ hands
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Genomic medicine. Personalized 
medicine. Precision medicine.
When it comes to interpreting and applying big data in health care,  
people may not agree on the best terminology. Most agree on one  
thing: Big data is an abstract, intimidating concept. 
DNA sequencing generates millions of data points for a single individual. 
Clinical trials yield massive amounts of treatment information. e 
electronic health record (EHR) expands with every patient encounter. 
And wearable tness trackers and apps — which measure steps taken, 
food consumed, heart rate, blood pressure and sleep patterns, open up  
a whole new area of possibility.
Big data is coming at medical professionals from all directions.  
Many have no idea how to eectively leverage it for patient care.
Philip R.O. Payne, PhD, is an internationally recognized leader in 
informatics, a eld that translates big data into actionable knowledge.  
As inaugural director of the university’s Institute for Informatics,  he  
leads the way he speaks — at double speed. In 20 months of existence, the 
institute has made signicant inroads at this large, decentralized university.
The Institute for Informatics 
—  also known as I2 — 
sits at the center of all 
big data initiatives at 
Washington University.  
It provides an academic 
and professional home  









181795_p7-13_Informatics_CC17.indd   8 5/21/18   7:06 PM
outlook.wustl.edu
For Payne, the path forward is clear. 
“If you ask physicians what they want, it’s  
the equivalent of a ‘patients like mine’ button on 
their electronic device,” he said. 
“ey tell us, ‘Given the patient that’s in front 
of me right now, show me similar patients who 
have been seen in the past six months, one year  
or 10 years. What treatment decisions were made? 
Who had the best outcomes? Who didn’t?’ 
“Physicians want to know, based on their 
wisdom and the wisdom of colleagues, how to 
optimize outcomes for the patient in front of them.”
Information overload
Provider burnout nationally is at an all-time high, 
with doctors citing such factors as job complexity and 
having too few hours in the day. By some estimates, 
EHR upkeep requires 31 percent of physicians’ time. 
A few decades ago, doctors could stay abreast  
of medical advances by reading scholarly journals. 
Now, it’s virtually impossible to keep up with the 
constant ow of information.
“Human short-term memory is optimized to 
remember seven pieces of information at a time, 
plus or minus two,” said Payne, also the Robert J. 
Terry Endowed Professor. “Informatics is essential 
to guring out how we connect the dots between 
those millions of data points, contextualize them 
and deliver them back to clinicians who may have 
only 10 minutes with a patient to interpret and act 
on that information.”
Payne envisions a new landscape — where 
doctors and researchers have the necessary tools 
and expertise to extract meaningful information 
within vast data sets. 
When many people hear the word informatics, 
Payne said, they associate it with interpreting the 
human genome, but that’s just one aspect of the 
institute’s work.
A top priority is improving EHR eciency.  
e EHR requires a mental shi for some physicians 
who are used to free-form documentation of 
patient encounters on paper versus a more rigid, 
checkbox system that perhaps even inuences 
medical thinking. Many clinicians nd it clunky, 
burdensome and disruptive. Institute team 
members are shadowing clinicians at the point of 
care to design technologies that adapt to workow.
Eciently designed systems can close the gap 
between digesting the data and making clinical 
decisions, Payne said. “e real challenge is not 
getting more data. It’s guring out what to do  
with what we already have.” 
Recently, Payne and David H. Gutmann, MD, 
PhD, the Donald O. Schnuck Professor and director 
of the Neurobromatosis (NF) Center at Washington 
University, employed informatics to predict 
symptom severity in children with NF1, a genetic 
disorder that causes brain and nerve tumors, as well 
as autism spectrum disorder (ASD). NF1 varies 
widely in severity and symptoms — from harmless 
brown spots on the skin and benign bumps to optic 
gliomas and malignant cancers. Parents don’t know 
which symptoms might manifest in their child.
The institute is actively 
training the next generation 
of informatics specialists.  
Here, Andrew Michelson, MD, 
left, a pulmonary and  
critical care fellow, and  
Sean Yu, a biomedical 
informatics doctoral student 
in the Payne-Lai lab, discuss 
analytical methods to 
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A data-driven approach, Payne said, is going 
to be a key dierentiator as institutions compete 
to provide exceptional care in an information-
rich era. Within its storehouses, big data holds 
the answers to pressing medical questions of our 
time; it has the power to develop drugs faster at 
lower cost, speed diagnosis, deliver on the 
promise of personalized, or precision, medicine, 
and improve quality of life.
A home advantage
Harnessing this power requires an environment 
that’s built to rapidly translate discovery out of 
the lab and into the clinic. 
Washington University, in partnership with 
BJC HealthCare, stands uniquely poised to lead 
on the informatics frontier, with key strengths in 
medicine, basic science, cancer, genomics, 
radiology, public health, social work, business 
and engineering, among others. Nearby sits the 
200-acre Cortex Innovation Community, a 
thriving hub for bioscience research, 
development and commercialization.
“We have one of the best genome institutes 
and one of the most productive and most 
impactful basic science research enterprises  
in the world,” Payne said. “We have some of  
the smartest care providers that you will meet. 
We have a unique living laboratory between 
Washington University Physicians and  
In a matter of hours, using computer analytics 
and existing NF1 patient data, Gutmann and 
Payne improved risk models that others had 
created following months of painstaking 
deliberation in conference rooms. With even 
greater specicity, they outlined various NF1 
subtypes, their trajectories and associations with 
optic gliomas and ASD. 
is information allows families to plan ahead, 
and alerts clinicians as to whether additional 
imaging or other interventions are warranted. 
“Precision medicine isn’t always about curing,” 
Payne said. “We can improve quality of life by 
illuminating the unknown. It’s also helpful for the 
clinician in the exam room, who is facing imaging 
reports, EHR data, gene sequencing results, maybe 
a social/behavioral evaluation report — and an 
anxious child and an anxious parent. We are 
relying on physicians to integrate on demand and 
make the best possible decision. at’s a source of 
stress for providers, who have limited time and an 
EHR that isn’t designed very well.
“But if we can integrate that data and say to 
those providers, ‘is patient has an 80 percent 
probability of developing an optic glioma and here 
are the outcomes for the last 10 children you saw 
similar to this,’ then we’ve allowed them to get 
down to the really important information and 
have a conversation with the family and not just  
sit there clicking and pointing and typing.
“at’s the real promise if we do all the things 
we’re talking about.”
“ Precision medicine isn’t 
always about curing.  
We can improve quality 
of life by illuminating 
the unknown.”  
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BJC HealthCare, where we have a large academic 
referral center, plus regional hospitals and primary 
care practice sites in urban and rural environments. 
“We have all the pieces we need to study what 
the future of health care looks like. Very few U.S. 
academic health centers are truly primed to take 
advantage of the health-care information age.” 
Until the institute’s launch, the university had 
all the raw pieces, except one. Although pockets  
of informatics strength existed — including 
leadership in the Human Genome Project, the 
Connectome Project and eorts to understand  
the microbiome — there was no central academic 
and professional home for informatics science  
and practice.  
Every School of Medicine department chair 
contributed funding from department reserves  
to establish the Institute for Informatics, also 
known as I2.
One patient, one record
Aer putting critical team members in place, 
institute leaders turned their attention to their 
rst, most fundamental task: Getting everyone 
within this expansive, 15-hospital system and 
medical school on the same page.
is June, with the institute’s active 
participation, the medical school and BJC 
HealthCare will roll out the Epic electronic health 
record system on the academic campus. It already 
has been launched in many of BJC HealthCare’s 
community hospitals. Once fully implemented, 
Epic will replace more than 50 standalone EHR 
systems that had been used by individual 
physician groups, specialty clinics, hospitals and 
even departments within the hospitals. Previously, 
outpatient data generated through Washington 
University Physicians (faculty practice plan) was 
not connected to hospital inpatient data. And 
some records were still paper-based.
As Sam Bhayani, MD, chief medical ocer  
of Washington University Physicians, explains,  
the medical center draws patients who live hours 
away and who have complex problems and see 
multiple specialists.  
Bringing data into one centralized location 
eliminates the need for patients to recall their  
entire medical history, such as the date of their last 
tetanus shot or prescription dosages, and will reduce 
treatment redundancies, potentially saving money, 
and help eliminate harmful drug interactions. It also 
allows clinicians to view patients holistically and 
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When Philip R.O. Payne, PhD, previously chair of the Department of Biomedical Informatics at The Ohio State 
University, signed on to become the institute’s founding director,  
he brought longtime colleagues with him.
 
This allowed for rapid deployment in targeted areas:
•  Speeding pace of discovery out of the lab into human studies
•  Building systems that improve how physicians treat patients
•  Using data to improve health of communities
 
Most faculty affiliated with the institute, which is housed in the 
Division of General Medical Sciences, will hold dual appointments  
in other departments and schools. This is part of a strategy to 
extend the institute’s reach across the university. An informatics 
expert embedded in anesthesiology or pediatrics, for example,  
will collaborate on projects related to these subjects.
Key informatics faculty investigators
Clinical research informatics
Chief Research Information Officer  
Albert M. Lai, PhD, an expert in informatics 
infrastructure who specializes in solving 
problems in the clinical domain. He oversees a 
core services team of programmer analysts, 
software engineers, database administrators, 
data analysts and bioinformaticists. 
Population health informatics
Randi Foraker, PhD, MA, FAHA, who applies 
informatics techniques to solve problems 
in the population health domain. She also 
serves in the Institute for Public Health.
Applied clinical informatics 
Po-Yin Yen, PhD, RN, an assistant professor 
at the Goldfarb School of Nursing at Barnes- 
Jewish College, who works with frontline 
caregivers to understand daily workflow and  
improve health information technology.
Launching  
the institute









consider all factors 
across the continuum  
of care. What should 
emerge is a more 
comprehensive picture  
of a person’s health care, 
including total cost of care. 
is, however, is only  
half of the vision. Patient 
information must be returned 
back to investigators as they 
consider new ways to solve 
complex health-care problems. 
Data mining within a 
decentralized system has been  
an arduous, inecient task.
“For some patients, we had  
very little data. All we knew is  
what happened during their hospital 
stay,” said Chief Research Information  
Ocer Albert M. Lai, PhD. “If you’re  
a researcher trying to understand 
optimal care delivery, it’s basically 
impossible given this fragmented view.”
A new research paradigm
A centralized EHR has revolutionary research 
implications for Washington University — 
joining together and unlocking access to  
more than 6 million records of inpatient and 
outpatient care. 
“We want to translate data into knowledge,” 
Payne said. “We want to create a system where 
what we learn from each patient informs how we 
treat other patients and what questions we ask in 
the lab. In turn, we want what we learn in the lab 
to benet patients more quickly. 
“Right now, we have clinical investigators 
seeing patients. But they go back to their labs  
and they don’t have access to the data generated  
by their own patients, at least not to the degree 
necessary to test basic hypotheses. We need to 
make that data more accessible.”
e real forward leaps in innovation will  
come as the institute builds out a large, integrated 
database — known as the Research Data Core 
(RDC) — that links all data. e RDC powerhouse 
will include the common EHR, which feeds a 
continuously updated stream of patient data, plus 
data from any remaining legacy or departmental 
clinical systems. Plans call for the addition of 
genomic and biospecimen information. 
Sources
Data is generated 
through the EHR, 





Data is integrated in the 
Research Data Core, a centralized 
warehouse managed by statistical 
data analysts. Here, various 
approaches can be used to  
analyze data — from machine 
learning to visualization.
Output
From this analysis, decision-support 
tools can be designed to assist 
physicians at the point of care. 
These tools — such as reminders 
for preventive care or alerts about 
potentially dangerous situations —  
can be deployed through laptops,  
tablets and mobile phones.
Impact
Precise, knowledge-based interventions  
benefit doctors, researchers, patients,  
communities and policymakers.
When data becomes treatment
12  Washington University School of Medicine
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Statistical data analysts within the institute will 
manage the RDC. ese informatics professionals 
will help researchers pull data from the central 
system, design studies and maintain patient 
condentiality. ey and other team members are 
available to educate, answer questions and analyze 
and visualize data in meaningful ways. 
rough self-service tools, researchers will be 
able to access the RDC and do some analysis at 
their own computers. 
Informatics leaders say a new partnership with a 
company called MDClone also has the potential to 
fast-track research. Washington University is the rst 
U.S. academic institution to have this technology.
Under current federal regulations, investigators 
must wait weeks or months to begin research 
projects involving real patients. For each project, 
researchers must le paperwork and wait for 
approval from an institutional review board (IRB), 
an administrative body that protects the rights 
and welfare of human research subjects. Following 
approval, researchers then must wait for a data 
analyst to pull the necessary data before research 
can get underway. 
MDClone’s unique niche is its ability to create 
synthetic data — data that looks like an actual patient 
population, but isn’t. Data engines yield synthetic 
data that is statistically identical to original protected 
health information, but without privacy concerns.
“With MDClone, you could eectively have no 
time delay,” Lai said. “If you think of an idea, you 
can pull up the data and analyze it, right then and 
there, from the computer in your oce, potentially 
make discoveries on the data, with zero risk to 
patient privacy.” 
If the data looks promising, researchers can 
follow the standard IRB steps to conrm the  
result with real data. If not, Lai said, they can  
just move on to the next question.
e institute is testing MDClone’s performance 
via pilot research projects. Pending a successful 
evaluation, MDClone will become part of the 
RDC infrastructure.
Creating eciencies in research saves time and 
allows grant dollars to stretch farther, Payne said, 
which, in turn, will attract top U.S. researchers.
Speeding discovery
Payne hopes to speed up the process of taking 
discoveries into clinical trials. Currently, it can 
take 15 to 20 years and more than $1 billion to 
develop therapeutic agents for disease. 
Treatment solutions, however, are waiting  
to be found in big data. Repurposing or using  
new combinations of approved drugs, which already 
have passed toxicity tests, could save valuable time. 
Using an informatics concept known as 
“machine learning,” computers can be 
programmed to comb through clinical and  
drug data, going back through decades of  
medical literature, analyzing billions of variables,  
to discover meaningful patterns and new uses for 
existing medicines. 
Payne, also a cancer researcher, points to 
malignant melanoma as one example. Frontline 
therapies are eective at causing tumors to 
disappear, but patients oen become resistant 
within 12 months of the rst treatment. By  
using public data and computational methods, 
researchers have found drugs — developed for 
other diseases — that could be combined with 
melanoma frontline therapies to prevent or delay 
resistance onset. So far, Payne’s research team has 
taken this combination therapy all the way to 
animal models, and they did it in about a year.
Once a therapeutic agent is ready to move to 
clinical trials, the RDC also should make it 
quicker and more ecient to identify test subjects. 
 
Enhancing human health
e dream, Payne said, is to use big data not only 
to help the sick, but also to keep people well, to 
intervene in the communities where they live, 
work and play, and not just inside our hospitals. 
An evolving EHR likely will include more data 
about patients’ daily activity levels, gathered 
through smartphones and tness trackers, and 
other health inuencers, such as water quality in 
the home, proximity to grocery stores and family 
support networks. 
Big data has the power to promote wellness  
by generating a picture of the whole patient — 
connecting genes and environmental factors to 
social factors and outcomes.  
“e institutions that gure out how to bring 
all these pieces together will be the rst to begin 
delivering personalized, precision medicine,” 
Payne said. “Rather than treating people as a 
function of averages, personalized health care  
that is powered by big data is about enabling 
physicians to provide the right care at the right 
time, based on the unique characteristics of the 
patient in front of them.”
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Radiation beam 
        to the heart
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Doctors halt deadly rhythm 
with noninvasive therapy 
B Y  R E B E C C A  B O Y L E
In the early days of his irregular heartbeat, Clarence Mankin would pass out before his implanted debrillator kicked in to reboot his 
heart. He would wake up a bit later, dazed but alive. 
Aer his doctor adjusted the device’s sensitivity, it 
would shock his heart before he fainted, which, in  
some ways, was worse. Mankin could feel it coming — 
the lightheadedness, the dizziness — and he’d know  
to brace himself for the jolt. 
 “It’s like a good thump in the chest. It feels like 
you are going to die,” he said. “I’d try to grab hold of 
something, or nd something to sit down on, which 
occasionally I was able to do.” 
Mankin, 74, a retired Lutheran pastor in Atlanta, 
Illinois, used to pride himself on walking 10,000 steps a 
day, which he tracked with his wrist pedometer. But when 
he started feeling the jolt all the time — at one point, he 
was having 11 episodes a day — he stopped walking. 
He stopped driving. 
He stopped leaving the couch.
About 3 million Americans experience arrhythmia, 
in which the heart beats too fast, too slow, or too 
irregularly. One such form, ventricular tachycardia,  
is the leading cause of sudden cardiac arrest.
An unlikely pairing between a School of Medicine 
cardiologist and a radiation oncologist, however, has 
led to a revolutionary treatment: Mankin is one of the 
earliest patients to sustain a beam of radiation directly 







181795_VT_CC17.indd  15 5/16/18  8:16 PM
Summer 2018
Ventricular tachycardia (VT) results  from other cardiac problems. Mankin, who served in the U.S. Army during 
the Vietnam War, had his rst heart attack at 44, 
which he attributed to Agent Orange exposure. 
Injury to the heart, commonly from a heart attack, 
causes some cells to die, forming scar tissue. When 
heart cells are damaged in this way, they might 
not function correctly, causing the heart to short-
circuit. is makes it beat out of sync, which means 
the heart might not be able to pump enough blood 
throughout the body, and it can even stop entirely.
Standard treatments include medications, 
debrillators and a procedure known as catheter 
ablation. Patients must be sedated for this invasive 
procedure as doctors thread ne tubes through  
the femoral vein, up into the heart. A tiny electrode 
tip, no larger than a headphone jack, selectively 
burns away heart cells that have gone haywire. 
e procedure can last from four to 10 hours, 
and recovery can take several weeks. Although 
physicians have developed precise ablation 
techniques to ensure they destroy as many 
wayward cells as they can, the treatment doesn’t 
always work. It also has a cluster of side eects, 
from infections to bleeding problems. In a 2016 
study, half of patients who underwent catheter 
ablation saw their tachycardias return. 
e same was true for Mankin.
en Mankin’s cardiologist referred him  
to Phillip S. Cuculich, MD, a heart rhythm 
specialist and an associate professor of medicine  
at Washington University.
Cuculich and Cli G. Robinson, MD, an associate 
professor of radiation oncology, recently had teamed 
up to provide a new type of arrhythmia treatment, 
one that cardiologists nationally are calling a game 
changer for patients with few remaining options. 
Mankin agreed to give it a try. 
To undergo the procedure, he donned a specially 
designed vest covered in 252 electrodes (as compared  
to 12 for a typical electrocardiogram). 
en Cuculich briey induced VT in Mankin 
using his debrillator. is allowed him to 
produce a panoramic map of Mankin’s heart. 
Later, Mankin lay inside a cylindrical chamber. 
A custom mold held him in place to prevent him 
from moving or breathing too deeply. Robinson 
used the map to direct an intense, focused beam 
of radiation at his heart. 
e high-energy particle stream is typically 
used to blast away cancer cells, and, during normal 
use, Robinson does everything he can to avoid 
hitting the heart. But this time, his particle beam 
intentionally zapped malfunctioning cells that  
were causing Mankin’s heart to beat out of sync.
On average, the procedure takes less than  
15 minutes.
“I’ve spent my entire life as a trainee and an 
attending physician thinking about ways to avoid 
dosing healthy tissues,” Robinson said. “But this is 
already an injured region. If you think about it as 
a diseased part, where Phil would have no problem 
going in with a catheter to burn that area, well, we 
are doing the same thing. ere are other ways to 
get energy inside the body.”
16  Washington University School of Medicine
To treat arrhythmia,  
cardiologist Phillip S. 
Cuculich, MD, performs 
catheter ablation. For  
this procedure, the patient 
must be sedated as Cuculich 
threads fine catheters 
through the femoral vein, 
up into the heart, to burn 
away malfunctioning cells. 





Success rates and 
complication rates 
are being evaluated 
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Mankin was awake throughout the radiation 
therapy, which took place Sept. 8 at Barnes-Jewish 
Hospital. When it was over, he sat up, swung his 
legs o the table, and walked out of the room.  
He felt no pain. 
On a warm January day, Mankin visited 
Cuculich’s oce for a follow-up appointment. 
Cuculich downloaded data from his implantable 
debrillator, which tracks each time it gives 
Mankin a jolt. Aer the appointment, Cuculich 
printed out the device’s history on a piece of paper, 
and strode into Robinson’s oce in the radiation 
oncology department.
“Look at this,” Cuculich said, grinning as he 
thrust the small square paper into Robinson’s hand. 
Robinson’s eyes widened: “Wow!” And then the 
oncologist, still seated in his chair, started dancing.
e sheet of paper was marked with what 
looked like a bar graph. e bottom axis was time, 
and the vertical axis depicted every instance the 
device was activated. 
Cuculich pointed out the three months prior 
to the Sept. 8 radiation treatment. It looked like a 
forest: A spike each day, some very tall and some 
shorter, referencing the number of jolts each day 
from the device. en Cuculich pointed to Sept. 8,  
and the months aer Mankin’s procedure. e 
forest had been cleared. e device had not activated 
at all. e tachycardia was gone.
Cuculich and Robinson both laughed.  
“at is amazing,” Robinson said.
More than three months later, Mankin hasn’t  
had a single jolt from his debrillator. By February,  
he was walking 5,000 steps a day. “It’s hard to 
describe. Now when I walk, I don’t feel like 
something terrible is going to happen to me,” 
Mankin said. “I don’t know if this will extend  
my life or not, but it has made the quality of  
my life much better.”
When no other options exist
Mankin is one of about two dozen patients 
enrolled in a clinical trial led by Cuculich and 
Robinson. e ENCORE-VT trial follows an 
initial case study from April to November 2015 
with just ve patients, which the physicians 
conducted to prove their technique would work. 
e results were published in e New England 
Journal of Medicine in January. 
A vest covered in 252 
electrodes allows Phillip 
S. Cuculich, MD, center, to 
produce a panoramic map 
of a patient’s heart. Cliff G. 
Robinson, MD, right, uses 
this map to direct a focused 
beam of radiation at the 
heart to treat arrhythmia. 
Biomedical engineer Yoram 
Rudy, PhD, invented the vest.
R E G U L A R  H E A R T B E A T
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“Even if you could non-invasively image the 
heart, we still required entry into the body with a 
catheter to x it,” Cuculich said. “It became clear 
that the place to make an impact was to non-
invasively treat it.”
As part of the School of Medicine’s focus 
on translational research, Cuculich met with 
neurosurgeon Albert H. Kim, MD, PhD, to  
discuss using ultrasound technology. Kim 
recommended Cuculich meet with Robinson.  
For his part, Robinson was looking for new  
ways to use stereotactic radiation — a very  
precise, high-energy dose of radiation — beyond 
cancer treatment. 
“When we rst met to discuss this, I was  
really concerned about how to hit a 5 mm area  
in a moving, beating heart,” Robinson said.  
“But Phil’s rst question was, ‘How big of an area  
can you treat?’ And I said, ‘is is going to be a 
good friendship.’ Because as radiation oncologists, 
we don’t treat parts of tumors. We treat the whole 
kit and caboodle.” 
Cuculich and Robinson started meeting 
regularly to discuss each other’s specialties and 
learn about their patients. Each had to relearn 
terminology and techniques he hadn’t studied  
since medical school. 
“at was one of the keys to this initial success, 
that we came together and talked about it,” Robinson 
said. “at this could happen is one of the unique 
things about being at Washington University.”
e physicians developed a technique that 
relies on multiple imaging methods. MRI, CT 
Like Mankin, all patients so far have had 
ventricular tachycardia that has not responded  
to standard treatments.
In the rst clinical trial, the ve patients 
collectively experienced 6,577 episodes of  
VT in the three months before their radiation 
treatment. In the nine months aerward, they 
experienced four.  
“It has the potential to benet a substantial 
number of people,” said William G. Stevenson, 
MD, professor of medicine at Vanderbilt University 
Medical School, who was not involved in the research.
Cuculich spent several years rening techniques 
to map the heart in four dimensions — the three 
physical dimensions, plus time — to nail down 
the precise regions that are malfunctioning. e 
technique, known as electrocardiographic imaging, 
was developed by Yoram Rudy, PhD, the Fred Saigh 
Distinguished Professor of Engineering, director of 
the Washington University Cardiac Bioelectricity 
and Arrhythmia Center, and Cuculich’s mentor. 
But a more detailed picture of heart dysfunction 
was not enough, Cuculich said.
Cliff G. Robinson, MD, and 
Kim Maserang, RT (T), 
prepare to treat a patient 
with stereotactic radiation, 
a very precise, high-energy 
dose of radiation. 
“ We have created an entirely non-
invasive process to map and treat 
arrhythmia, and we can do it in less 
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and PET scans combine with the electrode 
vest to produce a detailed map of the heart and 
pinpoint where arrhythmias are coming from. e 
imaging process involving patients takes several 
hours, occasionally spread over multiple days. 
“en Cli and I sit down together and 
collaborate over this information, and we come 
to a conclusion about where the scar is, so we 
are as precise as possible. We want to avoid any 
structures that are important to the heart, and 
keep the potentially damaging energy within the 
scar,” Cuculich said. 
To Robinson, that push and pull — how deep 
to go, how much tissue to take and how much to 
leave alone — is much like cancer treatment. Some 
patients, like Mankin, have large areas that must be 
treated. e burning tip used in catheter ablation is 
only about 3.5 millimeters across, roughly the size 
of a Sharpie tip. In some people, the cells that cause 
the heart to beat out of sync are not reachable with 
the tiny catheter tip. is is especially true for cells 
deep within the heart muscle. e radiation beam 
can penetrate deeper, targeting all the faulty cells.
Robinson said he was concerned some patients 
would be fearful of the word “radiation,” but 
both physicians said their patients have been 
less resistant than they expected, in some cases 
because they were desperate for any solution. 
Mankin said the doctors helped him understand 
how it would work, and why it could be so 
eective. “It’s novel, but if you think about it, 
they’ve been using the gamma knife on cancer 
surgeries for years now,” he said.  
With such a high dose of radiation, even at a 
very small site, there is a risk of toxicity and ill 
eects on the surrounding organs and tissues. So 
far, patients in the initial study and in the ongoing 
clinical trial have done well, Robinson said. In the 
initial study, patients reported no complications 
or pulmonary symptoms during treatment or 
immediately aer. Some people did experience 
mild inammation in the lung adjacent to the 
target, but that resolved within a year, according 
to the study. Still, the potential long-term eects  
of the radiation dose are unknown.
“If this is to be used in younger, less-ill  
patients, the issue of collateral damage will 
become more relevant,” said Roy John, PhD, 
professor of medicine at Vanderbilt University 
Medical Center. He and Stevenson coauthored an 
editorial explaining the procedure’s potential in 
e New England Journal of Medicine. 
Radiation therapy likely will complement, 
rather than replace, ablation and other procedures  
cardiologists have used for many years. It provides  
another option for VT patients who have exhausted 
standard therapy options, including catheter 
ablation, and are facing one-year survival rates 
below 20 percent.
 “When you get complex forms of heart 
disease that are responsible for a lot of complex 
circuitry, then there might be an advantage to 
an approach that is more extensive, rather than 
precise,” said Francis Marchlinski, MD, director 
of cardiac electrophysiology at the University of 
Pennsylvania, who was not involved in the study. 
Robinson and Cuculich are nalizing their 
results from the ENCORE-VT trial, which included 
18 patients along with Mankin. Early results, they 
say, are promising.
“We have created an entirely non-invasive 
process to map and treat arrhythmia, and we  
can do it in less than 10 minutes,” Robinson said.  
“is approach can fundamentally change the  
way we approach these heart rhythm problems.”
Top: This image is a fusion 
of a CT simulation scan and 
PET/CT. The PET/CT shows 
viable heart tissue, outlined 
in pink, as a structure to 
avoid with radiation. The 
red line is the target area. 
The green and cyan lines 
mark safety margins to 
account for motion (patient 
breathing and heart beat).  
Bottom right and left show, 
respectively, the coronal  
view and sagittal view.
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Holly and Ben Allen welcome 
their new baby, Max, in the 
Women & Infants Center.
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Critical  
connections
New integrated center changes  
care model for women and babies
B Y  K R I S T I N A  S A U E R W E I N
A new center on the Washington University Medical 
Campus is transforming health care for women and 
babies in the region. e Women & Infants Center is 
housed within two 12-story inpatient towers recently 
built by BJC HealthCare: the Barnes-Jewish Parkview 
Tower and a St. Louis Children’s Hospital tower. A 
skywalk connects the labor and delivery areas in the 
Parkview Tower with an expanded Level IV newborn 
intensive care unit (NICU) in Children’s Hospital, 
drastically reducing the time it takes to transfer 
critically ill newborns. 
e center combines the most advanced facilities  
— allowing specialists to perform surgeries in the 
womb or manage risky deliveries — with beautiful, 
restful, comfortable spaces for patients. 
“Women and infants remain at the center’s heart.  
It’s as good as it gets,” said George Macones, MD,  
head of the Department of Obstetrics and Gynecology. 
Other tower oors signicantly enhance and 
expand inpatient cancer care and pediatric care. 
e improvements stem from a three-year design 
planning process involving input from nearly 800 
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W O M E N ’S  
A S S E S S M E N T  C E N T E R
This area allows women who 
think they may be in labor 
or who have an emergency 
gynecological issue to bypass  
the emergency room. Specialists 
who handle women’s health 
issues are on call and can  
quickly make an assessment.
CO M M A N D  C E N T E R
In the command center,  
nurses, doctors and other staff 
can monitor vital statistics for 
patients in labor or undergoing 
surgery. The stations monitor  
18 labor and delivery rooms  
and three ORs in real time. 
OPERATING ROOM SIZE
As many as 40 medical 
professionals can work in the 
largest operating room, which 
is designed for emergencies, 
for complex operations such 
as in-utero surgeries or for 
multiple births. 
MONITORING SYSTEM
Cameras are positioned over bassinets 
in the OR and areas where medical 
staff attend to newborns. The cameras  
let mothers watch their new babies 
even when they’re not holding 
them. This is especially helpful for 
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PAT I E N T  R O O M
Spacious, private rooms have 
windows overlooking Forest Park 
or rooftop gardens. The rooms are 
divided into three zones: space 
for family members to visit or 
spend the night; a place for mom 
and baby to rest; and areas that 
allow clinicians to do their work. 
W O M E N ’S  WA L K
This hallway was created for 
laboring women, so they won’t 
have to walk heavily trafficked 
areas. Glass walls let in natural 
light, illuminating work from 
Midwestern artists. Rails and 
benches are available for those 
who need a hand or a break. 
Caring for mom
Mothers-to-be who deliver at the Women & Infants  Center do so in an environment equipped with the top 
medical expertise and technology to treat serious conditions 
that may aect a pregnant woman or fetus. Barnes-Jewish 
Hospital annually cares for about 700 women from eight 
states who need specialized obstetric care for deliveries 
involving multiple births, pregnancy 
complications, fetal abnormalities and 
congenital defects in utero.
e labor and delivery oor has three 
operating rooms, including one for 
maternal-fetal surgeries that is state- 
of-the-art and spacious enough to 
accommodate up to 40 health-care 
workers. “is is the room where we do 
procedures on a fetus while still in the 
womb,” said George Macones, MD, the 
Mitchell and Elaine Yanow Professor and 
head of the Department of Obstetrics 
and Gynecology. “Having extra space is 
critical. One procedure, for instance, may include physicians 
and nurses from obstetrics, fetal medicine and anesthesia.” 
Altogether, 3,300 babies were born last year at Barnes-Jewish 
Hospital. e center oers 52 private obstetric rooms, in addition 
to 18 labor and delivery rooms. e rooms have sleeper couches 
for family, ample outlets for charging electronics and built-in 
storage stocked with supplies for diapering and feeding. Android 
tablets installed on over-the-bed tables make it easy for the 
patient to contact the doctor, order food and access the internet.
e center’s care extends to all women with the new, 12-bed  
Women’s Assessment Center, which allows OB-GYN patients 
to bypass the general emergency room to receive treatment for 
ovarian cysts, hysterectomies and other conditions. 
“We take care of women in all reproductive phases,” 
Macones said. “It’s one stop for women’s health.”The three new operating rooms bring 
together advanced technology, medical 
efficiencies and a focus on patients. 
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S KY WA L K
A skywalk links the Barnes-Jewish 
Parkview Tower and Children’s 
Hospital. Before this skywalk, 
any trip between delivery rooms 
and the NICU — for newborns or 
mothers — required a quarter-mile 
journey through corridors and up 
and down elevators. Now the trip 
takes seconds. 
N I C U
The newborn intensive care unit 
is designed for families. Private 
rooms promote bonding and 
breastfeeding, and sleeper sofas 
and lockers make it easy for 
moms and other family to visit. 
Mothers can pump breast milk 
in private spaces and store it in 
in-room refrigerators.
COMMUNICATION TOOL
Caregivers wear badges that 
show their location in real time 
and record when they enter 
and leave rooms. When in need 
of immediate assistance, they  
can press the badge to send 
an emergency alert. In rooms 
with TVs, the badges trigger a 
display of the name, title and 
photo of doctors and nurses to 
help patients know who’s who.
PROTECTIVE EQUIPMENT
Even basic things like how often 
protective gowns are restocked 
can make a difference in health 
care. Cabinets designed to hold 
personal protective equipment 
(PPE), such as gloves and gowns, 
are in consistent locations and 
require refills only once daily, 
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N I C U  E C M O 
The NICU is equipped to provide  
extracorporeal membrane 
oxygenation, or ECMO, in which a 
machine oxygenates the blood of 
infants who can’t breathe on their 
own. Children’s is one of the few 
hospitals in the Midwest with the 
expertise to use this technique. 
AU TO M AT E D  G U I D E D 
V E H I C L E   AG V 
Robots called automated guided 
vehicles, or AGVs, transport 
supplies from the delivery dock 
to supply rooms and haul trash  
and other waste. AGVs have their 
own dedicated corridors and 
elevators, so patients will likely 
never see them. 
Best for baby
Seconds count when treating a critically ill newborn.  Before the center opened, health-care workers transporting  
an infant had to walk one-fourth of a mile from labor and 
delivery to the NICU. Now, physicians, nurses and family 
members have immediate access to the baby, thanks to the 
110-foot skywalk connecting the two hospitals.
“We can’t aord to waste any time aer 
the mother gives birth,” said F. Sessions  
Cole, MD, the Park J. White, MD, Professor  
of Pediatrics, executive vice chair of 
pediatrics and chief medical ocer at  
St. Louis Children’s Hospital. “e skywalk 
allows us to treat babies immediately so we 
can provide the best care possible.”
e expanded NICU oers 37 private 
rooms, two of which accommodate 
multiples, bringing the total number of 
NICU beds to 125. e short skywalk 
jaunt from the postpartum rooms also 
promotes mother-baby bonding. “We 
include the mom as part of the infant’s health therapy,” said 
Cole, director of the Division of Newborn Medicine in the 
Department of Pediatrics. “Babies whose moms hold and talk 
to them oen experience better health outcomes. For example, 
babies born with opioids in their system may experience less 
irritability and physical discomfort when moms hold them.”
Intertwining mom in a baby’s health-care plan also 
means encouraging self-care, a feat made easier because 
medical appointments for postpartum mothers are in the 
center. “is eliminates obstacles to health care such as 
transportation,” Cole said. “Many moms put all their energy 
toward their babies and neglect themselves. But a well-cared 
for mom makes for a happier baby.”
e expansion also adds 96 private patient rooms on six 
pediatric oors, addressing the need for more beds.
The remodeled and expanded newborn intensive care unit 
(NICU) will hold 150 beds when the expansion is complete. 
The NICU design was informed by the latest neonatal care 
research, including studies on the importance of avoiding 
loud noises. The ceilings and flooring reduce noise. Private 
rooms cut down on infection.
INROOM CHARTING AND C ARE BOARD
Nurses and doctors don’t have to trundle around  
a computer on a cart to record a patient’s progress.  
Each room has its own computer, which folds 
into the wall like a Murphy bed. This in-room 
charting further reduces hallway traffic, keeping 
patient areas quieter. 
“ We can’t afford 
to waste any 
time.” 















181795_p20-25_WomenInfant_CC18.indd   25 5/21/18   7:51 PM
Spring 201826  Washington University School of Medicine 7

































University of California- 
San Francisco
FAMILY MEDICINE
Michael Snavely  
NEUROLOGY
Sarah Kaufman  
PSYCHIATRY
Susan Shen
University of Southern  
California
ORTHOPAEDIC SURGERY
Ramin Lalezari  
THORACIC SURGERY
Jonathan Labin




F L O R I D A
Jackson Memorial Hospital 
ORTHOPAEDIC SURGERY
Michael Rizzo
G E O R G I A
















On Match Day, March 16, thousands of physicians-to-be across the U.S. learned  
where they will train as medical residents after graduation. Of the 119 graduating 
Washington University medical students, 42 will train at Barnes-Jewish Hospital 
and four at St. Louis Children’s Hospital. Altogether, this year’s class will be 
represented at hospitals in 21 states. The largest group of students — 31 —  
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Avril Coley  
SURGERYPRELIMINARY
Max Riley
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N E W  Y O R K
Hospital for Special Surgery
ORTHOPAEDIC SURGERY
Gregory Schimizzi




New York Presbyterian  




New York Presbyterian Hospital-
Weill Cornell Medical Center
INTERNAL MEDICINE
Xiaodi Wu
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University of Texas Medical School
OBSTETRICS AND GYNECOLOGY
Gregory Opara







U T A H
University of Utah  
Aliated Hospitals
PLASTIC SURGERY  
INTEGRATED
Bo Overschmidt
W A S H I N G T O N
Kadlec Regional Medical Center
FAMILY MEDICINE
Jennifer Farley
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Match Day 2018 participants 
from former School of 
Medicine classes:
 
Anchal Bansal (2017 
graduate),  Anesthesiology, 
Barnes-Jewish Hospital
Michael Lamb (2001 graduate), 
Anesthesiology, University of  
Texas Medical Branch, Galveston 
Adam Letvin (2017 graduate),  
Internal Medicine, University 
Hospitals, Columbia, Missouri 
Jennifer Jupitz Pitts 
(2014 graduate), Radiology-
Diagnostic, University of 
Wisconsin Hospital and 
Clinics, Madison 
Tara Rao (2017 graduate), 
Internal Medicine-Primary 
Care, University of Wisconsin 
Hospital and Clinics, Madison 
Tammy Ruth (2013 graduate),  
Pediatrics, University of 
Washington Affiliated 
Hospitals, Seattle
See more photos online:
wumcnews.org/match2018
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Gaining
mobility
New strategies to preserve  
hip function, improve outcomes
Jackie and Randy Baker understand the pain and loss of mobility associated with arthritis — and the relief of recovery. To address their 
arthritis, doctors at the School of Medicine’s 
Department of Orthopaedic Surgery replaced their 
hips and guided them through rehabilitation. Now, 
with their mobility restored, the 
Bakers are passionate about bringing 
the gi of restoration to others. 
Hip surgeon John Clohisy, MD, the 
Daniel C. and Betty B. Viehmann 
Distinguished Professor and chief of 
Adult Reconstructive Surgery, 
performed the Bakers’ surgeries. 
Physiatrist Heidi Prather, DO, 
professor and chief of physical 
medicine and rehabilitation, advised 
the Bakers on alternative methods of 
relief prior to the surgeries.
rough their interactions with Clohisy and 
Prather, the Bakers learned about the physicians’ 
eorts to advance the treatment of musculoskeletal 
disorders. As a result, the Bakers decided to make a 
series of nancial gis supporting the research. 
e Bakers’ gis will help the physicians nd 
solutions that range from new surgical alternatives  
to a fundamental shi in the care model.
B Y  C H A N N I N G  S U H L
John Clohisy, MD
Heidi Prather, DO
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Investigating arthritis
Traditional treatment of advanced 
hip arthritis has centered on 
joint replacement surgery. ese 
procedures are very eective for 
pain relief but can be associated 
with limited function and long-
term implant failure requiring a 
second, riskier revision surgery. 
For nearly two decades, Clohisy 
and his collaborators have focused 
on pre-arthritic and early arthritic 
hip disorders and hip joint 
replacement. e multidisciplinary 
team has established a world-
renowned clinical practice, 
research unit and resident/fellow education programs. 
Yet, there is still a critical need for additional research to 
improve understanding of hip arthritis causes.
“Future strategies to cure arthritis must focus on early 
diagnosis and innovative treatments to preserve the natural 
hip joint and prevent disease progression,” Clohisy said.
ese initiatives are aimed at early detection of hip 
disease; evaluation of newer surgical alternatives that 
correct abnormal hip anatomy leading to arthritis onset 
and progression; arthritic disease staging; and clinical 
outcomes of joint preservation procedures. 
Clohisy’s team is investigating biological factors that  
can be used for disease staging and joint prognosis. To 
date, circulating biomarkers and joint tissue markers 
associated with hip arthritis progression and disease stages 
have not been clearly dened. 
As federal funds usually are not available during the 
early research phase, gis from private individuals provide 
extremely important start-up resources. 
“We hope that this research will result in signicant 
progress toward Dr. Clohisy’s vision to develop and rene 
innovative treatments to preserve natural hip joint function 
and prevent hip arthritis,” Randy Baker said.
 
Treating the whole patient  
Prather specializes in the conservative management of 
musculoskeletal conditions, pre-arthritic hip disorders  
and hip and lumbar spine connections. She is past 
president of the North American Spine Society  — the 
rst woman elected to the position — and internationally 
known in the eld.
e Bakers contributed in 2015 toward Prather’s  
musculoskeletal research. 
“Over the years, several members of our family  
have been treated by Dr. Prather,” Jackie Baker said.  
“We have been impressed not 
only by her care for us, but 
especially by her interest in 
improving patient outcomes 
and well-being through 
interdisciplinary approaches.”
In 2017, the couple learned 
of Prather’s plan to create the 
Living Well Center at Barnes-
Jewish West County Hospital, 
and eagerly provided funding. 
As the center works toward 
becoming a reality in 2019, 
Prather said, “e support of 
philanthropists like the Bakers 
is crucial.” 
A collaboration between the 
hospital and the School of Medicine, the proposed center 
will provide comprehensive, interdisciplinary medical 
services for patients with musculoskeletal disorders. 
A team of health-care professionals will identify patients 
at high risk for poor treatment outcomes (based on existing 
medical, physical and behavioral health disorders), develop 
individualized care plans for these patients and meet 
regularly to discuss their progress and any treatment barriers. 
is wellness center concept is unique because it 
provides health-care services, such as smoking cessation, 
nutritional counseling and exercise instruction, which 
third-party payers oen do not cover. 
rough this personalized, holistic approach, the  
center will give patients self-care tools to positively 
impact their well-being. “e end goal is for patients to 
self-manage their musculoskeletal disorders and have 
improved overall health that is sustainable,” Prather said. 
“For surgical patients, the goal is improved pain outcomes 
and functionality with reduced risk of complications, in 
addition to improved health.”
Prather said she has not found another musculoskeletal 
care model that incorporates all factors known to aect 
treatment outcomes. 
Eventually, the pilot center may expand into a regional 
center that anyone can access. 
“By breaking down barriers to coordinated care, we  
hope the center will become a model for other health-
care facilities,” said Jackie Baker, “and ultimately improve 
patient outcomes and the cost eectiveness of the  
health-care system.” 
St. Louisans Jackie and Randy Baker have made a series of
gifts supporting arthritis research and recovery initiatives.
“ The support of philanthropists 
like the Bakers is crucial.”




Family, researchers team up 
to cure — or even prevent —  
Alzheimer’s disease
A bequest by the late  Daniel J. Brennan, MD,  is supporting signicant 
advancements in Alzheimer’s disease 
research at the School of Medicine. e 
disease aects 5.5 million Americans — a number 
expected to climb rapidly as people live longer.
Following Brennan’s death in 2010, the estate gi 
created the Daniel J. Brennan, MD, Research Fund 
in the Charles F. and Joanne Knight Alzheimer’s 
Disease Research Center (Knight ADRC). In 2017, at 
the family’s request, a portion of the gi was used to 
establish the Daniel J. Brennan, MD, Professorship 
in Neurology, further extending its impact.
Beau Ances, MD, PhD, MSc, second 
from left, becomes an endowed 
professor. Joining in on the 
celebration are (from left): David 
H. Perlmutter, MD, executive vice 
chancellor for medical aairs and 
dean of the School of Medicine; 
Chancellor Mark S. Wrighton; and 
Daniel J. Brennan II. 
B Y  C H A N N I N G  S U H L
30  Washington University School of Medicine
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Born in St. Louis, Brennan trained at Saint Louis University 
— earning undergraduate and medical degrees and completing 
a general surgery internship and residency and a plastic and 
reconstructive surgery residency. A gied plastic surgeon, 
Brennan practiced at St. John’s Mercy Medical Center (now 
Mercy) until 1997 as a member of Plastic Surgery Aliates.
As a longtime benefactor of medical education and 
research, Brennan chose Washington University School of 
Medicine for his estate gi because of its national leadership 
in Alzheimer’s disease research.
Brennan’s son, Daniel J. Brennan II, said the gi reects 
the things his father valued in his own career. “My father 
dedicated most of his adult life to medicine — and caring 
for people,” he said. “It was his passion. To have his name 
associated with such a prestigious university, and a leader  
of Alzheimer’s research, ts with his desire to leave a mark. 
It also ts with his desire for excellence.”
 
Uncovering the progression
John C. Morris, MD, the Harvey A. and Dorismae Hacker 
Friedman Distinguished Professor of Neurology, leads the 
Knight ADRC, located in the Department of Neurology.  e 
center and its clinical research arm — the Memory and Aging 
Project (MAP) — are at the forefront of a worldwide eort to 
uncover key causal factors in Alzheimer’s disease and improve 
early diagnosis, with a goal of nding more eective treatments, 
an eventual cure or even preventing the illness entirely. e 
researchers believe that beginning preventive treatment before 
brain damage occurs is essential to halting disease progression.
Morris leads a team focused on improving early-stage 
diagnosis, identifying preclinical stages of Alzheimer’s 
disease by biomarker and neuroimaging studies, evaluating 
new drugs for the treatment of dementia and establishing 
phenotypes for inherited forms of Alzheimer’s disease and 
other dementias. Volunteer research participants, including 
those who are aging normally and those with dementia, and 
family members have been major contributors. ey take 
part in annual assessments through the MAP and various 
other studies, such as clinical drug trials, and provide 
biological and imaging specimens. 
Morris also is the principal investigator of the Adult 
Children Study, a long-term study of adult children of 
Alzheimer’s patients — led by the School of Medicine — 
that aims to dene who is likely to develop the disease and 
when, and to establish a timeline for how quickly the disease 
will progress. e study, which began in 2005 with funding 
from the National Institute on Aging of the National 
Institutes of Health (NIH), already has helped identify some 
of the molecular and structural changes in the brain that 
occur in the decades before a person is diagnosed with the 
neurodegenerative disease.
Fulfilling a legacy
According to Dan Brennan II, establishing a professorship 
was an important step in fullling his father’s wishes.  
“As long as I can remember, he spoke of a desire to have an 
endowed professorship in his name as part of his legacy,”  
he said. “And I’m proud to have my daughters — Mackenzie, 
Livia, Danielle and Sylvia — involved and witness the impact 
of the legacy that my father has le behind.”
In February, neuroimaging expert Beau Ances, MD, PhD, 
MSc, was installed as the inaugural Daniel J. Brennan, MD, 
Professor of Neurology. Ances is a professor of neurology, 
neurosciences and molecular microbiology and microbial 
pathogenesis at the School of Medicine and of biomedical 
engineering at the School of Engineering & Applied Science.
He also is a member of the Knight ADRC and the Hope 
Center for Neurological Disorders.
e Ances lab has been at the forefront of developing 
novel neuroimaging methods to understand the timeline 
of change seen in both sporadic Alzheimer’s disease and 
autosomal dominant Alzheimer’s disease. e vision of the 
Ances lab is to nd neuroimaging biomarkers that will allow 
for Alzheimer’s disease diagnosis and evaluate the ecacy of 
potential therapies.  
While Alzheimer’s research primarily has focused on the 
accumulation of the protein amyloid beta, researchers now are 
paying closer attention to another protein, tau. Long associated 
with the disease, tau is not easy to visualize through imaging 
and, as a result, has not been thoroughly studied.  
Using a new binding agent that makes tau protein visible 
on positron emission tomography (PET) scans, Ances and 
his colleagues have shown that measures of tau are better 
markers of the cognitive decline characteristic of Alzheimer’s 
than measures of amyloid beta protein. is allows for a 
better understanding of Alzheimer’s progression.
John C. Morris, MD, director of the Charles F. and Joanne Knight 
Alzheimer’s Disease Research Center, performs a neurological exam  
on a patient. A long-term study of adult children of Alzheimer’s  
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1950S
Max Heeb, MD ’53, 
who practiced general 
surgery for more than 45 
years in rural Missouri, 
received a distinguished 
service award from the 
University of Missouri 
School of Medicine on 
April 21, 2017. He is author of the book 
“Max the Knife: The Life and Times of a 
Country Surgeon.”
Roger Meyer, MD ’55, stays active with 
volunteering, supporting peace activities 
with Rotary International, Peace Action with 
the Unitarians and the Physicians for Social 
Responsibility, and serves on the Oregon 
Health & Science University BRAINet 
board as historian. His work with Rotary 
International’s Fellowship of Doctors as vice 
president is helping promote telemedicine 
and end-of-life practices. He also enjoys a 
busy family life with four of his six children 
in Portland, Ore., and looks forward to 
celebrating his 90th birthday in May.
1960S
Mordecai Blaustein, 
MD ’61, recently 
published an invited 
40-year update on 
an article he wrote 
when he was on the 
Washington University 
faculty in 1977. In this widely cited article, he 
postulated that an endogenous digitalis-like 
compound plays a role in the pathogenesis 
of hypertension. The update is Blaustein’s 
personal account of how he and his col-
leagues purified and identified endogenous 
ouabain (EO) in human plasma. The article 
reviews the astonishing evidence that oua-
bain (first identified as a plant steroid that 
was used as an arrow poison for centuries) 
is an adrenocortical hormone. EO and its 
plasma membrane receptor, the sodium 
pump, are a novel endocrine system that 
influences behavior, cardiovascular func-
tion, fetal development and muscle fatigue. 
Blaustein chaired the University of Maryland 
Department of Physiology from 1979-2003 
and is still an active faculty member. His 
awards include the Pasarow Foundation 
Award for Cardiovascular Research, the 
American Heart Association Hypertension 
Council Novartis Award for Hypertension 
Research and the University of Maryland 
Baltimore 2002 Faculty Research Lecturer of 
the Year Award.
Kurt Studt, LA ’63, DE ’66, retired from 
active dental practice after more than 50 
years. During his career, he taught dental 
students at Washington University and 
at Southern Illinois University School of 
Dental Medicine. Studt is currently an 
adjunct faculty member in the dental 
hygiene program of St. Louis Community 
College at Forest Park.
Lynn Taussig, MD ’68, retired in 
December from the University of Denver, 
where he served as special adviser to the 
provost for life sciences for the past 12 
years. He previously served as president/
CEO at the National Jewish Medical and 
Research Center, now called National 
Jewish Health, and was on faculty at the 
University of Arizona College of Medicine, 
where he served nine years as chair of 
the Department of Pediatrics. Taussig 
is proud to have initiated the Tucson 
Children’s Respiratory Study in 1979, a 
major longitudinal study of asthma risk 
factors in 1,246 newborns. The study 
continues today. One paper emanating 
from this study has had nearly 4,000 
citations. Taussig is grateful for the many 
honors given by his peers and mentors, 
including the Alumni Achievement Award 
from Washington University School of 
Medicine, the Distinguished Achievement 
Award from the American Thoracic Society, 
the Kendig Award from the Academy of 
Pediatrics, The Founders Award from the 
Scientific Assembly on Pediatrics of the 
American Thoracic Society, and election 
into the Colorado Pulmonary Hall of Fame.
1970S
Richard Wahl, MD ’78, HS ’83, the 
Elizabeth E. Mallinckrodt Professor of 
Radiology and director of the Mallinckrodt 
Institute of Radiology, Samuel I. Achilefu, 
PhD, the Michel M. Ter-Pogossian Professor 
of Radiology, and Pamela K. Woodward, 
MD, professor of radiology, recently 
received a five-year, $933,700 grant from 
the National Institutes of Health (NIH) for 
Training Opportunities in Translational 
Imaging Education and Research (TOP-
TIER). This new interdisciplinary clinician-
scientist postdoctoral program will prepare 
residents and fellow trainees on how to 
bring preclinical imaging innovations to 
patients and the practice of medicine.
1980S
Joseph Moskal, MD ’81, 
chair of the Department 
of Orthopaedic Surgery 
for Carilion Clinic and 
the Virginia Tech Carilion 
School of Medicine, 
has been appointed 
to the Dean’s Council 
on Advancement for the Virginia Tech 
Carilion School of Medicine. The council 
is a committee of volunteers created 
to advance the stature of the medical 
school by providing guidance, assistance, 
advocacy and philanthropic investment in 
support of the school’s strategic objectives.
Raymond Curry, MD ’82, 
was recognized by the 
Northwestern University 
Feinberg School of 
Medicine with the 
creation of a named 
professorship in medical 
education, endowed by 
an anonymous donor in honor of his 16 years 
Find your friends.
Classnotes are organized first by  
year of degree/training completion 
and then in alphabetical order. 
How about you?
Share your news via the online 
form at wumcnews.org/classnotes. 
Submissions will be printed in 
a subsequent issue of Outlook 
magazine as space allows. Photos 
are welcome.
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David Jin, EN ’06, MD ’11, is a clinical 
research fellow in gastroenterology, 
hepatology and endoscopy at Brigham and 
Women’s Hospital at Harvard Medical School.
Jesse Otero, MD ’11, PhD ’11, is an 
orthopaedic surgeon at the University of 
Iowa Hospitals and Clinics. He is married 
with children.
Catherine Butler, MD ’12, is a research 
nephrology fellow at the University of 
Washington.
Adam Rouse, EN ’04, SI ’12, MD ’12, is a 
research assistant professor in neuroscience 
at the University of Rochester and received 
a National Institutes of Health (NIH)/ 
National Institute of Neurological Disorders 
and Stroke K99/00 grant in April 2017.
Lucy Zhang, MD ’12, 




Group at its Daly  
City and Burlington, 
Calif., offices.
Yi Wang, MD ’13, of Houston, recently 
was married and traveled to Italy on her 
honeymoon and describes it as a beautiful 
and poignant experience. She is happy to 
report having survived Hurricane Harvey 
without much damage. Wang works as a 
pediatrician at Legacy Community Health.
Megan Cook, PT ’14, was married to 
Aaron Shoppa in September 2017. She is 
a physical therapist at Advocate Children’s 
Hospital in Oak Lawn, Ill.
Jennifer Jupitz, MD 
’14, is stationed at Camp 
Lejeune in North Carolina 
serving as the physician 
to a squadron in the U.S. 
Marine Corps. She was 
married in 2016, and 
she and her husband 
welcomed a baby boy in fall of 2017.
of service to the institution as vice dean for 
education. Curry is now the senior associate 
dean for educational affairs at the University 
of Illinois College of Medicine and clinical 
professor of medicine and medical education 
at the University of Illinois at Chicago.
Sándor J. Kovács, PhD, MD, HS ’85, 
professor of medicine and of cell biology 
and physiology, was honored with a Lifetime 
Achievement Award from the Barnes-Jewish 
Hospital Medical Staff Association. The award 
was presented at the association’s semi-
annual general staff meeting, April 13, 2017.
1990S
Audrey Shillington, SW 
’87, SW ’91, GM ’93, 
director of the Colorado 
State University School 
of Social Work, assumed 
responsibilities as 
associate dean for 
academic affairs in the 
College of Health and Human Sciences in 
June 2017. Shillington remains director of 
the social work school and is professor of 
epidemiology at the University of Colorado 
School of Public Health. She was a National 
Institute of Mental Health postdoctoral fellow 
and earned a master’s degree in psychiatric 
epidemiology from Washington University 
School of Medicine. She has published in 
the areas of psychometrics, epidemiology, 
prevention and intervention work aimed at 
adolescent and young adult risk behaviors. 
She has been principal investigator and 
co-investigator on grants totaling more than 
$14 million, including those from the National 
Institutes of Health (NIH), the National 
Institute on Drug Abuse and the National 
Institute on Alcohol Abuse and Alcoholism. 
Her current work focuses on intervention and 
prevention related to the changing landscape 
in legalization of recreational marijuana use. 
Michael Raney, MD ’94, a radiologist  
with West County Radiological Group in  
St. Louis, was elected secretary-treasurer  
of the Missouri Radiological Society.
Bryan Gibby, PT ’95, is a certified wound 
specialist at St. Luke’s Elks Wound Center in 
Boise, Idaho.
Deborah Veis Novack, MD ’95, PhD ’95,  
participated in the Rally for Medical 
Research in Washington, D.C., in September 
2017. This annual event brings together 
300-plus researchers, clinicians and patient 
advocates from hundreds of organizations 
to meet in the offices of senators and 
representatives to demonstrate the value 
of medical research to all citizens. Through 
this type of advocacy, Congress has 
provided $2 billion increases in National 
Institutes of Health (NIH) funding each of 
the last two years, and a similar increase is 
proposed for the FY2018 budget.
Bryan Meyers, HS ’98, 
chief of the general 
thoracic surgery 
section at Washington 
University School of 
Medicine, has been 
named chair of the 
American Board of 
Thoracic Surgery. He will serve as chair for 
two years.
Edward Garon, MD ’99, 
director of the Thoracic 
Oncology Program at the 
Jonsson Comprehensive 
Cancer Center at the 
University of California, 
Los Angeles, and associate 
professor of medicine 
in the Division of Hematology-Oncology 
at David Geffen School of Medicine, joined 
LUNGevity’s scientific advisory board, a 
group of 19 world-renowned scientists and 
researchers who guide LUNGevity’s scientific 
strategy and research program. LUNGevity 
focuses on early detection of lung cancer.
2000S
Jimmy Kerrigan, MD ’10, is an inter-
ventional cardiology fellow at Cleveland 
Clinic and is married with children.
Vanessa Williams, LA ’06, MD ’10, is  
an assistant professor of radiology at  
the University of Kansas. She is married 
with children.
Tassy Hayden, LA ’07, MD ’11, practices at 
Southampton Healthcare in St. Louis, a large 
primary medicine group with an emphasis 
on caring for the LGBT community.
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Berlin was diagnosed with cancer while 
in medical school. Following his diagnosis, 
his parents moved to St. Louis from 
Massachusetts to offer additional support. 
Berlin is survived by his wife; his parents, 
Kenny Berlin, MD, and Marsha Ross-Berlin, 
DMD; a brother, Josh Berlin; a sister, Jessie 
Berlin; and his grandmother, Maxine Berlin.
Arthur Z. Eisen, MD, a 
physician-scientist who 
founded and led the 
Division of Dermatology, 
died Sunday, Nov. 12, 
2017, in St. Louis after a 
short illness. He was 88.
Eisen founded the 
division in 1967 and remained its director for 
more than 30 years. During that tenure, he 
was the Winfred A. and Emma R. Showman  
Professor of Dermatology. Until his retirement 
last year, he remained active in clinical 
medicine and resident education.
“Dr. Eisen was one of the true giants in  
the field of dermatology,” said Lynn Cornelius, 
MD, director of the Division of Dermatology. 
“He embodied the quintessential ‘triple 
threat’ throughout his illustrious career — 
outstanding in research, clinical medicine  
and education.”
Eisen was considered a longtime leader 
in connective tissue research. He focused 
on the genetic underpinnings of skin 
diseases and the role enzymes play in 
remodeling tissue, and was particularly 
interested in the cells that synthesize 
collagenase-1 in the dermal layer of skin.
He earned a bachelor’s degree from the 
University of Buffalo in 1951, a master’s 
degree from Brown University in 1953, and 
a medical degree from the University of 
Pennsylvania in 1957. He completed an 
internship, residency and fellowship at the 
University of Rochester School of Medicine 
and Dentistry. 
Eisen is survived by his wife of 59 years, 
Mimsie Eisen; their son, Marshall (Gail) Eisen; 
daughters Phyllis (Alex) Kane, and Leah 
(Steve) Pazol; and several grandchildren.
Stephen L. Johnson, 
PhD, a national leader 
in the field of zebrafish 
genomics and a 
professor of genetics, 
died at his home Friday, 
Dec. 15, 2017, after a 
long struggle with 
rheumatoid arthritis. He was 56.
Johnson guided the development of 
zebrafish as an important research model, 
similar to fruit flies and mice. With transparent  
embryos, zebrafish are ideal for studying 
growth and development.
Johnson’s zebrafish studies have shed 
light on how tissues regenerate and how 
organisms control the size of their organs.  
He was particularly interested in 
understanding cells called melanocytes, 
which are best known for governing skin 
pigmentation and are the cell type affected 
in the deadliest form of skin cancer, 
melanoma. Johnson developed methods to 
track the fate of these cells as they develop 
from the early embryo to the adult zebrafish.
Johnson earned a bachelor’s degree in 
chemistry and molecular biology at Vanderbilt 
University, followed by a doctoral degree in 
genetics from the University of Washington, 
Seattle. He continued postdoctoral training at 
the University of Oregon before joining the 
Washington University faculty in 1996.
Johnson is survived by his sister,  
Susan C. Johnson; his brother, Lee  
Johnson; and several nieces.
William M. Landau, MD,  
a professor emeritus of 
neurology, died in his 
sleep Thursday, Nov. 2, 
2017, at his home in 
University City. He was 93.
Landau was a 
professor of neurology 
from 1954 to 2012 and served as head of 
the Department of Neurology from 1970 to 
1991. He was the longest-serving faculty 
member at the School of Medicine.
Landau specialized in movement 
disorders such as Parkinson’s disease, but 
his interests ranged widely. With Frank 
Kleffner, of the Central Institute for the 
Deaf, he identified and described Landau-
Kleffner syndrome, a rare disorder in which 
Summer 2018
David A. Bensinger, LA 
43, DDS, former dean of 
Washington University’s 
School of Dental 
Medicine, died Saturday, 
July 22, 2017, in San 
Francisco. He was 91.
Bensinger joined 
the faculty in 1948 as an instructor of 
dental medicine. He became an associate 
professor in 1956, was named assistant 
dean in 1967, associate dean in 1973 and 
full professor in 1976. A major renovation 
of the School of Dental Medicine building 
was completed under his supervision in 
1972. In 1987, Bensinger was appointed 
dean, serving until his retirement in 1989. 
The Washington University Alumni 
Association named him Alumnus of the 
Year in 1968, honoring his work to prevent 
closure of the school the previous year.
A specialist in periodontics, Bensinger 
served as president of the Midwestern 
Society of Periodontists; he also served as 
president of the Missouri Dental Association 
and was also a fellow of both the American 
College of Dentists and the International 
College of Dentists.  
He is survived by his wife of 42 years, 
Susanna; children and step-children Judith 
(William) Haynes, Scott (Vicki) Bensinger, 
Ruth Hartman (Gary Wolff), Emily (Avraham) 
Eisbruch and Sara Yashar (Mayer z”l); 11 
grandchildren and three great-grandchildren. 
Ari Nachum Berlin, MD, 
a pediatric intern at  
St. Louis Children’s 
Hospital and a 2017 
graduate of the School 
of Medicine, died Feb. 
23, 2018, in St. Louis, 
after a 2 ½-year battle 
with pancreatic neuroendocrine cancer.  
He was 27.
Berlin grew up near Boston. He earned  
a bachelor’s degree in chemistry in 2012  
at Rice University.
He met his future wife, Hallie Morris, 
while both were students at the School of 
Medicine. The couple married Jan. 7, 2017, 
and worked together for a brief time at  
St. Louis Children’s Hospital. Morris, MD,  
is a fellow in newborn medicine.
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children lose the ability to speak and 
respond to language. He also studied  
how patients fared who were revived with 
CPR after their hearts had stopped beating, 
and concluded that the risk of severe, 
debilitating brain damage was under-
appreciated. He advocated for more limited 
use of the procedure.
The Department of Neurology established 
the William & Pudge Landau Lectureship in 
Neuroscience and Society in honor of Landau 
and his wife, known as Pudge, whom he 
married in 1947. Along with his scientific 
accomplishments, Landau was known for his 
commitment to social justice.
Landau was born just a few blocks from 
Washington University in 1924. He started 
college at the University of Chicago in 1941, 
but the United States’ entry into World War 
II accelerated his college career, and after 
just two years, he returned to St. Louis to 
begin medical studies at Washington 
University School of Medicine. He was 18.
In addition to his daughter, Julie Landau-
Taylor, he is survived by three sons, David 
Landau of St. Louis, John Landau of New 
Jersey and George Landau of Philadelphia; 
11 grandchildren; and four great-
grandchildren.
Arthur DeCosta Loewy, 
PhD, professor of 
anatomy and of 
neuroscience, died 
Saturday, Dec. 2, 2017, 
of complications related 
to inflammatory bowel 
disease and other health 
issues. He was 74.
Upon joining the School of Medicine 
faculty in 1975, Loewy focused his research 
on the ways the brain regulates bodily 
functions such as blood pressure. He is best 
known for discovering the anatomical basis 
of the fight-or-flight response. Early in his 
career, he used radioactively tagged 
molecules to trace the pathway that 
connects the brain to the pacemaking 
neurons in the heart.
Loewy earned a bachelor’s degree in 
mathematics from Lawrence University in 
Appleton, Wis., followed by a doctoral 
degree in anatomy from the University of 
Wisconsin, Madison. 
Loewy was preceded in death by his 
wife, Arleen Loewy, who also had worked at 
Washington University. In addition to his 
son, Adam Loewy, he is survived by his 
daughter-in-law, Philippa (Rudolph) Loewy; 
his long-term girlfriend, Karen Frahm; a 
grandson; and his daughter-in-law’s 
parents, Christy Twin and Larry Rudolph. 
John E. Majors, PhD, 
professor emeritus of 
biochemistry and 
molecular biophysics, 
died Wednesday, Jan. 
10, 2018, of a heart 
attack. He was 69.
Majors was known 
for key contributions to the field of 
molecular biology, particularly involving the 
expression of genes in yeast and viruses. He 
worked with a team led by Harold E. Varmus, 
MD, and J. Michael Bishop, MD, whose 
research revealing how viruses can cause 
cancer was honored with the Nobel Prize in 
Physiology or Medicine in 1989.
According to colleagues, Majors was 
deeply committed to mentorship and 
training, putting students at the center of 
his work. He served on the doctoral thesis 
committees of more than 100 graduate 
students in the Division of Biology & 
Biomedical Sciences (DBBS). In 2013, he was 
one of 10 DBBS faculty named to “The One 
Hundred Club,” honoring this achievement. 
Many of his former trainees have gone on  
to become leaders in their fields.
Majors earned a bachelor’s degree in 
physics from the University of Washington 
in 1970 and a doctoral degree in biophysics 
from Harvard University in 1977. He trained 
as a postdoctoral fellow in Varmus’ lab, then 
at the University of California, San Francisco 
— contributing to the discoveries that 
would later earn Varmus and Bishop the 
Nobel Prize. 
He joined the Washington University 
faculty in 1983. After his retirement in 2011, 
he continued teaching regularly for the 
university’s Department of Biology.
Majors is survived by his sisters, Anne 
Chick and Jane Sutherland, and their families.
Eric P. Newman, JD,  
St. Louis businessman, 
scholar and philanthropist  
— an alumnus and major 
benefactor to Washington  
University — died 
Wednesday, Nov. 15, 
2017, at his home in 
Clayton. He was 106 years old.
Born in St. Louis, Newman graduated 
from John Burroughs School in 1928 and 
Massachusetts Institute of Technology in 
1932. He graduated from Washington 
University’s School of Law in 1935.
Following World War II, Newman began 
his career at Edison Brothers Stores Inc., 
where he was an officer and served on the 
board until his retirement. From 1988-2005, 
he served as president of the Harry Edison 
Foundation.
One of the foremost American 
numismatists, Newman wrote more than 
100 books and articles, including the 
pioneering study “The Early Paper Money of 
America” (1967), which remains a standard 
in the field. His private collection of U.S. and 
Colonial American coins and paper money 
is considered one of the nation’s finest.
Newman and his family extended 
extraordinary generosity to a wide range of 
Washington University schools and 
programs. At the School of Medicine, the 
family helped underwrite the Eric P. 
Newman Education Center and endow two 
professorships, in addition to supporting 
many other programs.
Newman was preceded in death by his 
wife of 75 years, Evelyn. He is survived by 
his son, Washington University trustee 
Andrew E. Newman of St. Louis; daughter, 
Linda Newman Schapiro of New York; five 
grandchildren; and 10 great-grandchildren.
John A. “Jack” Pierce, 
MD,  former director of 
pulmonary and critical 
care and emeritus 
professor of medicine, 
died Friday, Nov. 24, 
2017, in St. Louis 
following a long battle 
with cancer. He was 92.
Pierce came to the university in 1967 as 
the first director of the Division of Pulmonary 
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1940S
Elbert H. Cason, MD ’42; Oct. ’17
Roger E. Fox, MD ’49; Jan. ’18
Louis O. Lambiotte, MD ’45; Nov. ’17
Rudolph J. Maffei, MD ’48; Oct. ’17
Annetta McMahon, NU ’42; Nov. ’17
Roberta G. Middelkamp, NU ’49; Feb. ’18
William W. Regan, MD ’47; Oct. ’17
David E. Smith Jr., MD ’44; Nov. ’17
1950S
Allie Dunlevy, NU ’50; Aug. ’17
Joan Edwards, NU ’51; Sept. ’17
Gerald E. Hanks, MD ’59; Dec. ’17
Robert J. Hickok, PT ’53, HA ’71; Jan. ’18
Carl A. Hirsch, MD ’59; Dec. ’17
Everett L. Jung, LA ’49, MD ’55; Nov. ’17
Jo Ann Koehler, NU ’53; Jan. ’18
Patricia Kolditz, NU ’51; Dec. ’17
Percy E. Luecke Jr., MD ’52; Oct. ’17
Jean Matthews, PT ’55; Oct. ’17
Larry L. McCune, DE ’55; Jan. ’18
Paul S. Meyer, DE ’55, GD ’58; Dec. ’17
Enoch E. Morrow, DE ’53; July ’17
May Yamamoto Omura, NU ’51; Aug. ’17
Lothar H. Pinkers, MD ’55; July ’17
Robert M. Roy, HS; Oct. ’17
Mary Lynne Ruddon, PT ’58; Nov. ’17
Olga S. Smith, OT ’55; Jan. ’18
1960S
Duane E. Christian, DE ’60; Oct. ’17
Richard P. Jacobs, MD ’69; Jan. ’18
Leonard Jarett, MD ’62; Jan. ’18
William G. Juergens Jr., MD ’61; Jan. ’18
Azmi H. Khazin, LA ’57, MD ’61; Dec. ’17
Elizabeth C. Sowa, MD ’63; Oct. ’17
H. Goff Thompson Jr., LA ’57, MD ’61;  
      Dec. ’17
Carol F. Williams, HS ’60; Jan. ’18
1970S
Sharon S. Crandell, MD ’74; Oct. ’17
Michael Bruce Deldin, MD ’75; Dec. ’17
1980S
Craig W. S. Howe, HS ’81; Jan. ’18
Kevin T. McDonagh, HS ’87; Dec. ’17
1990S
Richard Ceenan Tam, MD ’99; Jan. ’18
For full obituaries, visit: 
wumcnews.org/obits
and Critical Care Medicine. He also served as 
chief of pulmonary and critical care medicine 
at the St. Louis Veterans Affairs Medical Center.
In 1984, Pierce was named the inaugural 
Selma and Herman Seldin Professor of 
Medicine. He became an emeritus professor 
in 1993, but continued to work with medical 
students and trainees until recently.
Pierce created the first respiratory intensive 
care unit (ICU) at what was then Barnes 
Hospital, which was one of the first such ICUs 
in the country. He also launched and directed 
one of the first National Institutes of Health 
(NIH)-sponsored pulmonary research training 
programs in the country. 
Pierce’s research helped clarify the roles  
of specific enzymes in the development  
of emphysema. 
Pierce is survived by his wife of 33 years, 
Susan (Ellis) Pierce; his children, Sheryl, John 
Jr. (Margarita) and Robert (Dawn) Pierce; his 
wife Susan’s children, Kerstin Starzer (Daryl) 
and Nissa Fendler (Mark); 12 grandchildren; 
and four great-grandchildren.
Milton J. Schlesinger, 
PhD, professor  
emeritus of molecular 
microbiology, died of 
heart failure Friday,  
Oct. 27, 2017, at his 
home in Berkeley, Calif., 
after a long period of 
illness. He was 89.
Schlesinger was a professor of micro-
biology (later, molecular microbiology) from 
1964 until 1999. During his tenure, he twice 
served as acting head of his department.
Schlesinger wrote a definitive history of 
the microbiology department, starting from 
its inception to the present day. He was 
named an emeritus professor in 1999.
His work focused on diverse aspects of 
viral assembly and replication. “Milton was 
one of the first to use the power of defined 
viral systems to probe fundamental processes 
of protein folding and modification, in 
advance of the recombinant DNA revolution,” 
said Stephen M. Beverley, PhD, the Marvin A. 
Brennecke Professor and head of the 
Department of Molecular Microbiology.
Schlesinger and his wife of 62 years, 
Sondra Schlesinger, PhD — a Washington 
University professor emerita and an 
occasional scientific collaborator with her 
husband — moved to Berkeley in 2003,  
but were frequent visitors to St. Louis  
and maintained a strong interest in  
the department.
He is survived by his wife. 
Raymond H. “Ray” 
Wittcoff, an emeritus 
Washington University  
trustee and a member 
of the School of 
Medicine’s National 
Council since 2005, 
died Tuesday, Jan. 2, 
2018, at his home in Phoenix. He was 96.
Wittcoff was elected to the Board of 
Trustees in 1974. He and his wife, Roma, also 
an emeritus trustee and School of Medicine 
National Council member, have been long-
time supporters of Washington University.
The Wittcoffs helped fund university 
building projects, program initiatives, 
scholarships and professorships. 
A real estate developer, philanthropist, 
civic leader and visionary, Wittcoff helped 
bring public television to St. Louis as a 
co-founder of KETC/Channel 9. 
Wittcoff also was chair of the board  
of directors of Washington University 
Medical Center and of Jewish Hospital  
(now Barnes-Jewish Hospital). He was 
instrumental in inaugurating the 
Washington University Medical Center 
Redevelopment Corp. In 1986, he 
established the Raymond H. Wittcoff 
Professorship in Biological Chemistry at  
the School of Medicine.
A St. Louis native, Wittcoff earned a 
bachelor’s degree from the University of 
Chicago in 1942, then served as a Navy 
lieutenant in World War II. 
In addition to his wife, Wittcoff is 
survived by his son, Mark; daughter, 
Caroline; five stepchildren, Joel, Richard, 
Melanie, Marna and Debbie Broida; four 
grandchildren; seven stepgrandchildren; 
and one stepgreat-grandson.
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Medical student Iris Kuo visits 
with patient Jerry McCaleb.
First-year medical student Iris Kuo’s classmates were intrigued by the lovely haku lei — a floral crown — Kuo wore at White Coat 
ceremony in the fall. Eager to share her Hawaiian 
culture with classmates, the Honolulu native 
arranged a workshop to teach them how to make 
the colorful crowns. But before long, the idea 
blossomed into something even more meaningful: 
an opportunity to show kindness to patients coping 
with cancer.  Some 50 medical students, faculty, 
members of the Hawaii Club on the Danforth 
Campus, and St. Louis community members with 
ties to Hawaii, made the floral crowns. The crowns 
were delivered May 1 — Lei Day in Hawaii —to 
patients at Siteman Cancer Center.  “It was my hope 
that, through the haku lei, the patients would feel 
our hope, support and aloha for a moment in their 
healing process,” Kuo said. 
 
‘ When you make a lei, 
you’re putting a piece 
of yourself or your spirit 
into it for the recipient.’
Top: Kuo presents patients with oral crowns. Bottom: Maria Baggstrom, MD, left, 
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Changing the skyline  Two 12-story inpatient towers built by BJC HealthCare on the 
Washington University Medical Campus are enhancing patient care. One of the buildings is the Barnes-Jewish 
Parkview Tower, which offers roomy, modernized facilities for patients of Siteman Cancer Center and of the Women  
& Infants Center. The other is a St. Louis Children’s Hospital tower featuring an expanded newborn intensive care unit 
(NICU) and more pediatric beds. A skywalk now connects labor and delivery areas in the Parkview Tower with the 
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